Terpenoid ID | TKC065182 | |
Chirality | TKC065155 | |
Cell line | 0 | |
Protein target | 1 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 7 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC065182 | MCF7 | 98.0 | % | Activity | C4194 | ||
TKC065182 | NCI-H460 | NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460 | 106.0 | % | Activity | C4450 | |
TKC065182 | HT-29 | HT 29; HT29 | 91.0 | % | Activity | C4349 | |
TKC065182 | CCRF-CEM | CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C | 97.0 | % | Activity | C7953 | Orphanet_99861 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC065182 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 10900 | nM | IC50 |
TKC065182 | P15559 | NAD(P)H dehydrogenase [quinone] 1 | NQO1 | >20 | ug ml-1 | CD |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P18031 | PTN1_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 | PTN1_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
P18031 | PTN1_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 | PTN1_HUMAN | Obesity [ICD-11: 5B80-5B81] |
P18031 | PTN1_HUMAN | Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 | PTN1_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 | PTN1_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 | PTN1_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P15559 | NQO1_HUMAN | Choreiform disorder [ICD-11: 8A01] |
P15559 | NQO1_HUMAN | CNS anomalies syndrome [ICD-11: LD20] |
P15559 | NQO1_HUMAN | Inborn energy metabolism error [ICD-11: 5C53] |
P15559 | NQO1_HUMAN | Intellectual development disorder [ICD-11: LD90] |
P15559 | NQO1_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P15559 | NQO1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |